Home Institutions Yale clinical trials Institution Directory
Clinical trials at Yale Sites in New Haven, CT
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:28 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1243
Current sort
Recently updated
Campus scope
Yale, New Haven, CT
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 517–528 of 1,243 matching trials with a site at Yale, New Haven, CT.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Intracerebral Hemorrhage, Ischemic Stroke, Spironolactone
Interventions Spironolactone Pill Drug
Lead sponsor Yale University Other
Eligibility 18 Years and older
Enrollment 160 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2026
U.S. locations 5
States / cities New Haven, Connecticut • Winston-Salem, North Carolina • Philadelphia, Pennsylvania + 1 more
Conditions Parkinson's Disease
Interventions Standard of Care Other
Lead sponsor Bayer Industry
Eligibility 45 Years to 75 Years
Enrollment 300 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2033
U.S. locations 27
States / cities Phoenix, Arizona • Tucson, Arizona • Fountain Valley, California + 23 more
Conditions Sexual Risk Behavior for HIV-infection, Reproductive Health
Interventions PrEP Decision Aid, Generic Information Device · Other
Lead sponsor Yale University Other
Eligibility 18 Years and older · Female only
Enrollment 50 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2026 – 2027
U.S. locations 1
States / cities New Haven, Connecticut
Conditions Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
Interventions IV ICT01 Biological
Lead sponsor ImCheck Therapeutics, an Ipsen company Industry
Eligibility 18 Years and older
Enrollment 293 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 8
States / cities Gilbert, Arizona • Duarte, California • New Haven, Connecticut + 5 more
Conditions Advanced Liver Cancers
Interventions Atezolizumab, Bevacizumab 15 mg/kg, Tiragolumab, Tocilizumab, TPST-1120, Tobemstomig 2100 mg, Bevacizumab 10 mg/kg, Tobemstomig 600 mg, Tobemstomig 1200 mg, ADG126, IO-108 1800 mg, NKT2152, IO-108 1200 mg Drug
Lead sponsor Hoffmann-La Roche Industry
Eligibility 18 Years and older
Enrollment 518 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 16
States / cities Costa Mesa, California • Duarte, California • Orange, California + 11 more
Conditions Pain Management, Postoperative Pain
Interventions PCDD Generation 1 system Device
Lead sponsor Yale University Other
Eligibility 18 Years and older
Enrollment 60 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 1
States / cities New Haven, Connecticut
Conditions Breast Cancer Metastatic
Interventions Trastuzumab Deruxtecan Drug
Lead sponsor Yale University Other
Eligibility 18 Years and older
Enrollment 40 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 3
States / cities New Haven, Connecticut • Atlanta, Georgia • Rochester, New York
Conditions Major Depression Disorder
Interventions Spravato, IV Ketamine Drug
Lead sponsor Yale University Other
Eligibility Not listed
Enrollment 450 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 8
States / cities Milford, Connecticut • New Haven, Connecticut • Atlanta, Georgia + 5 more
Conditions Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C, Metastatic Lung Cancer, Advanced Lung Carcinoma
Interventions BBO-8520, Pembrolizumab, BBO-10203 Drug
Lead sponsor TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) Industry
Eligibility 18 Years and older
Enrollment 350 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2031
U.S. locations 23
States / cities Birmingham, Alabama • La Jolla, California • San Francisco, California + 19 more
Conditions Heart Transplant Rejection
Interventions Standard of Care Other
Lead sponsor CareDx Industry
Eligibility 15 Years and older
Enrollment 2,743 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2026
U.S. locations 67
States / cities Phoenix, Arizona • Little Rock, Arkansas • La Jolla, California + 50 more
Conditions Breast Cancer
Interventions Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression Drug
Lead sponsor NRG Oncology Other
Eligibility 18 Years to 60 Years · Female only
Enrollment 3,960 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2034
U.S. locations 1226
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 809 more
Conditions Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Stage II Renal Pelvis Cancer AJCC v8, Stage III Renal Pelvis Cancer AJCC v8
Interventions Pembrolizumab, Tivozanib, Biospecimen Collection, MRI, Computed Tomography, Biopsy, Questionnaire Administration Biological · Drug · Procedure + 1 more
Lead sponsor Alliance for Clinical Trials in Oncology Other
Eligibility 18 Years and older
Enrollment 1,040 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2037
U.S. locations 425
States / cities Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 339 more About this Yale institution page
What this page lists ClinicalTrials.gov records that list Yale in New Haven, CT as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by Yale University at any site , browse by condition , or browse by U.S. city .